Y-mAbs Enters into Exclusive Distribution Agreement with Adium Pharma S.A. for DANYELZA® (naxitamab-gqgk) and Omburtamab in Latin America

B7-H3 is an immune checkpoint molecule that is widely expressed in tumor cells of several cancer types.